Market Cap 5.45B
Revenue (ttm) 1.61B
Net Income (ttm) 282.33M
EPS (ttm) N/A
PE Ratio 53.05
Forward PE 33.51
Profit Margin 17.53%
Debt to Equity Ratio 0.00
Volume 23,880,200
Avg Vol 33,333,758
Day's Range N/A - N/A
Shares Out 523.92M
Stochastic %K 54%
Beta 1.03
Analysts Sell
Price Target $13.57

Company Profile

UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. It offers the UiPath platform, an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The company's UiPath platform includes the UiPath Maestro process orchestration and process intelligence; UiPath agent bui...

Industry: Software - Infrastructure
Sector: Technology
Phone: 844 432 0455
Address:
One Vanderbilt Avenue, 60th Floor, New York, United States
FreePeoplesofMiddleEarth
FreePeoplesofMiddleEarth Apr. 19 at 10:22 PM
$PATH just buy us out for $50 /share
1 · Reply
WallStreetBuyDip
WallStreetBuyDip Apr. 19 at 9:09 PM
How do you trade small + mid caps? Here's the result for Small + Mid cap stocks. Do you see why I only buy when H% is low? I have timestamps + buy fills for everything. The result speaks for itself. Next, I'll trade $PATH + $APPS
0 · Reply
sck2
sck2 Apr. 19 at 7:33 PM
$PATH that would be the "green light" for the turnaround. Are you holding PATH as a long-term play on AI, or are you looking for a short-term swing trade?
1 · Reply
sck2
sck2 Apr. 19 at 7:32 PM
$PATH * **The Turn:** Markets move in cycles. When the "AI Hardware" trade (chips/servers) becomes too expensive, capital typically rotates back into "AI Software" (applications). Analysts believe we are approaching a "key support level" where software is deeply oversold. ### 4. Key Dates to Watch | Event | Potential Impact | | :--- | :--- | | **Q2 2026 Earnings** | Watch for a "beat and raise" on revenue guidance (currently $345M$350M). | | **Share Buybacks** | The company has been aggressively repurchasing shares (21M+ shares recently). This reduces supply and supports the price. | | **Agentic AI Summit Results** | Watch for case studies from early adopters in Healthcare and Finance showing a **90% reduction** in manual tasks. | ### Summary: When will it turn? A sustained move back toward the **$15$18 range** likely won't happen until the market sees **Annual Recurring Revenue (ARR)** growth accelerate again. Right now, growth has slowed to about **9%–12%**.
0 · Reply
sck2
sck2 Apr. 19 at 7:30 PM
$PATH ### 2. Catalyst: The "Agentic AI" Pivot (Fiscal 2027) The biggest reason for the lag is that investors are worried AI "agents" will replace UiPath’s robots. Management’s counter-offensive is their new **Agentic Automation** platform. * **Timeline for Turnaround:** Management has stated that while 2026 is a "foundational year" for this tech, **Fiscal 2027** (which begins in early calendar 2026) is when they expect significant revenue contributions from these AI agents. * **The "Proof" Phase:** If UiPath can show during their next few earnings calls that customers are paying *more* for AI agents (rather than cancelling their old robots), the stock could re-rate upwards quickly. ### 3. Macro Market Rotation Software stocks collectively entered a **bear market** in early 2026, dropping 27% while chip stocks (like Nvidia) surged.
0 · Reply
sck2
sck2 Apr. 19 at 7:30 PM
$PATH Analyzing **UiPath (PATH)** right now is a lesson in "market psychology vs. fundamental reality." Despite the stock's recent lag, there is a clear roadmap for a potential turnaround, but it requires the market to move past its current "AI Fear" phase. Here is the outlook for a PATH turnaround based on the latest 2026 data: ### 1. The "Valuation Floor" Argument The stock is currently trading at a **Forward P/E of roughly 15x**, which is significantly lower than the industry average of **28x**. * **The Opportunity:** Goldman Sachs recently noted that the software sector is seeing a "record gap" between stock performance and actual earnings growth. * **Profitability:** UiPath has officially reached **GAAP profitability** (a major milestone for tech stocks). Usually, when a company proves it can make real money while the stock price is falling, value investors eventually step in to "catch the falling knife."
0 · Reply
hormoz1
hormoz1 Apr. 19 at 3:20 PM
$PATH shortxqueez. Massive upside.
0 · Reply
TheArtOfFinancialWar
TheArtOfFinancialWar Apr. 18 at 11:11 PM
$PATH in 2024 I said this stock is part of a 3-year-3-stock portfolio, and so 2027 is the year for this stock. In 2027 if the stock is still very beaten down, mobilize an extremely large position and get margin dry powder ready when it goes uptick and berserk. Good things take time.
1 · Reply
FreePeoplesofMiddleEarth
FreePeoplesofMiddleEarth Apr. 18 at 8:03 PM
$PATH $250 loading
1 · Reply
MorganHoratio
MorganHoratio Apr. 18 at 7:54 PM
20 Small Cap Stocks Across 20 Sectors — A 5-Year Framework(11-15) $SERV — Delivery Robotics $ZETA — AI powered marketing $EVER — Insurtech $PATH — Enterprise automation $ABCL — AI drug discovery All eyes are on $ZETA's upcoming earnings (April 30)—a critical litmus test for AI monetization. For $SERV, watch out for recent insider selling; while the narrative is strong, short-term profit-taking is a risk. Which of these "Pragmatic AI" sectors—Delivery, Marketing, or Automation—do you think will lead the pack in H2 2026? Drop your case in the comments!
1 · Reply
Latest News on PATH
UiPath Analysts Slash Their Forecasts After Q4 Results

Mar 12, 2026, 1:26 PM EDT - 5 weeks ago

UiPath Analysts Slash Their Forecasts After Q4 Results


UiPath Profit, Revenue Rise as AI Adoption Spreads

Mar 11, 2026, 4:57 PM EDT - 5 weeks ago

UiPath Profit, Revenue Rise as AI Adoption Spreads


What's Going On With UiPath Shares On Wednesday?

Mar 11, 2026, 12:31 PM EDT - 5 weeks ago

What's Going On With UiPath Shares On Wednesday?


Meta Shifts Spending, UiPath Surges, And Core PCE Ahead

Dec 5, 2025, 8:59 AM EST - 4 months ago

Meta Shifts Spending, UiPath Surges, And Core PCE Ahead

META


UiPath Earnings Show Accelerating Growth

Dec 4, 2025, 3:50 PM EST - 4 months ago

UiPath Earnings Show Accelerating Growth


UiPath Stock Soars. It's Looking More Like an AI Winner.

Dec 4, 2025, 10:47 AM EST - 4 months ago

UiPath Stock Soars. It's Looking More Like an AI Winner.


UiPath Stock Jumps After Q3 Earnings: Here's Why

Dec 3, 2025, 4:27 PM EST - 4 months ago

UiPath Stock Jumps After Q3 Earnings: Here's Why


UiPath Reports Third Quarter Fiscal 2026 Financial Results

Dec 3, 2025, 4:10 PM EST - 4 months ago

UiPath Reports Third Quarter Fiscal 2026 Financial Results


FreePeoplesofMiddleEarth
FreePeoplesofMiddleEarth Apr. 19 at 10:22 PM
$PATH just buy us out for $50 /share
1 · Reply
WallStreetBuyDip
WallStreetBuyDip Apr. 19 at 9:09 PM
How do you trade small + mid caps? Here's the result for Small + Mid cap stocks. Do you see why I only buy when H% is low? I have timestamps + buy fills for everything. The result speaks for itself. Next, I'll trade $PATH + $APPS
0 · Reply
sck2
sck2 Apr. 19 at 7:33 PM
$PATH that would be the "green light" for the turnaround. Are you holding PATH as a long-term play on AI, or are you looking for a short-term swing trade?
1 · Reply
sck2
sck2 Apr. 19 at 7:32 PM
$PATH * **The Turn:** Markets move in cycles. When the "AI Hardware" trade (chips/servers) becomes too expensive, capital typically rotates back into "AI Software" (applications). Analysts believe we are approaching a "key support level" where software is deeply oversold. ### 4. Key Dates to Watch | Event | Potential Impact | | :--- | :--- | | **Q2 2026 Earnings** | Watch for a "beat and raise" on revenue guidance (currently $345M$350M). | | **Share Buybacks** | The company has been aggressively repurchasing shares (21M+ shares recently). This reduces supply and supports the price. | | **Agentic AI Summit Results** | Watch for case studies from early adopters in Healthcare and Finance showing a **90% reduction** in manual tasks. | ### Summary: When will it turn? A sustained move back toward the **$15$18 range** likely won't happen until the market sees **Annual Recurring Revenue (ARR)** growth accelerate again. Right now, growth has slowed to about **9%–12%**.
0 · Reply
sck2
sck2 Apr. 19 at 7:30 PM
$PATH ### 2. Catalyst: The "Agentic AI" Pivot (Fiscal 2027) The biggest reason for the lag is that investors are worried AI "agents" will replace UiPath’s robots. Management’s counter-offensive is their new **Agentic Automation** platform. * **Timeline for Turnaround:** Management has stated that while 2026 is a "foundational year" for this tech, **Fiscal 2027** (which begins in early calendar 2026) is when they expect significant revenue contributions from these AI agents. * **The "Proof" Phase:** If UiPath can show during their next few earnings calls that customers are paying *more* for AI agents (rather than cancelling their old robots), the stock could re-rate upwards quickly. ### 3. Macro Market Rotation Software stocks collectively entered a **bear market** in early 2026, dropping 27% while chip stocks (like Nvidia) surged.
0 · Reply
sck2
sck2 Apr. 19 at 7:30 PM
$PATH Analyzing **UiPath (PATH)** right now is a lesson in "market psychology vs. fundamental reality." Despite the stock's recent lag, there is a clear roadmap for a potential turnaround, but it requires the market to move past its current "AI Fear" phase. Here is the outlook for a PATH turnaround based on the latest 2026 data: ### 1. The "Valuation Floor" Argument The stock is currently trading at a **Forward P/E of roughly 15x**, which is significantly lower than the industry average of **28x**. * **The Opportunity:** Goldman Sachs recently noted that the software sector is seeing a "record gap" between stock performance and actual earnings growth. * **Profitability:** UiPath has officially reached **GAAP profitability** (a major milestone for tech stocks). Usually, when a company proves it can make real money while the stock price is falling, value investors eventually step in to "catch the falling knife."
0 · Reply
hormoz1
hormoz1 Apr. 19 at 3:20 PM
$PATH shortxqueez. Massive upside.
0 · Reply
TheArtOfFinancialWar
TheArtOfFinancialWar Apr. 18 at 11:11 PM
$PATH in 2024 I said this stock is part of a 3-year-3-stock portfolio, and so 2027 is the year for this stock. In 2027 if the stock is still very beaten down, mobilize an extremely large position and get margin dry powder ready when it goes uptick and berserk. Good things take time.
1 · Reply
FreePeoplesofMiddleEarth
FreePeoplesofMiddleEarth Apr. 18 at 8:03 PM
$PATH $250 loading
1 · Reply
MorganHoratio
MorganHoratio Apr. 18 at 7:54 PM
20 Small Cap Stocks Across 20 Sectors — A 5-Year Framework(11-15) $SERV — Delivery Robotics $ZETA — AI powered marketing $EVER — Insurtech $PATH — Enterprise automation $ABCL — AI drug discovery All eyes are on $ZETA's upcoming earnings (April 30)—a critical litmus test for AI monetization. For $SERV, watch out for recent insider selling; while the narrative is strong, short-term profit-taking is a risk. Which of these "Pragmatic AI" sectors—Delivery, Marketing, or Automation—do you think will lead the pack in H2 2026? Drop your case in the comments!
1 · Reply
MeanReverter_
MeanReverter_ Apr. 18 at 3:20 PM
$PATH weekly chart starting to speak for itself. Clean higher-timeframe structure printing — weekly candles tightening after a long reset phase. You can see buyers consistently stepping in on dips, defending structure instead of letting price roll over. Momentum is shifting from compression → expansion setup. This is where weekly trends either ignite or stay stuck in accumulation purgatory. If this base holds, it’s the kind of multi-week setup traders wait months for: volatility contracting, then one decisive move defining direction. No noise here — just price doing what it does before expansion. Watching for follow-through or rejection at this level.
1 · Reply
AZ_09
AZ_09 Apr. 18 at 11:02 AM
$PATH Anthropic is using the same code with different lipsticks... Soon they will release their Claude Doctor and all hospitals will fire their doctors lol 😆
1 · Reply
LatteLove
LatteLove Apr. 18 at 3:44 AM
$PATH why is this POS down I thought it had a good bottom?
0 · Reply
LatteLove
LatteLove Apr. 18 at 3:40 AM
$PATH double bottom.
0 · Reply
awesomedaniel
awesomedaniel Apr. 18 at 3:10 AM
$PATH one of the worst stock performances driven by inside sales that I have seen in my lifetime. Embrassed I bought this at 17$ lol I won’t even sell it, I’ll just hold it for a reminder for the rest of my life
1 · Reply
Bigglesworth85
Bigglesworth85 Apr. 17 at 11:33 PM
$PATH to wealth or POVERTY?
1 · Reply
Carlos7144
Carlos7144 Apr. 17 at 11:06 PM
$PATH $MSFT $NOW $CRM https://x.com/codyhrountree/status/2045241883689939376?s=20
1 · Reply
NachoTheBull
NachoTheBull Apr. 17 at 10:00 PM
$PATH I wonder how much money shorting hedge funds are giving Anthropic to release Claude news every single week. It won’t be long before the market sees through this BS.
0 · Reply
ronirona
ronirona Apr. 17 at 9:57 PM
$PATH POS...Dan Dines
1 · Reply
motty1234
motty1234 Apr. 17 at 9:40 PM
$PATH Interesting day today Haven't really seen any institutional buying like signals I'm speculating it's due to the fact that they wanna keep the price low to be able to buy more because if they would buy more today, they would cause a gamma squeeze Let's look out for Monday and see if this theory is correct
0 · Reply
YeahtThePRo
YeahtThePRo Apr. 17 at 8:36 PM
$PATH Cuckpath is down again. Did that surprise me? Hell no.
1 · Reply
i_hope
i_hope Apr. 17 at 8:30 PM
$PATH I stopped loading in case next week it goes 9 again
1 · Reply